HRT Financial
TRAW icon

HRT Financial’s Traws Pharma TRAW Stock Holding History

HRT Financial’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$29K Sell
50,102
-41,118
-45% -$23.6K ﹤0.01% 4439
2026
Q2 		$76K Buy
+91,220
New +$126K ﹤0.01% 3680
2025
Q4 		– Sell
-12,573
Closed -$23K – 4214
2025
Q3 		$23K Buy
+12,573
New +$20.5K ﹤0.01% 2693
2021
Q2 		– Sell
-1,772
Closed -$663K – 3651
2021
Q1 		$663K Buy
1,772
+1,637
+1,213% +$617K 0.01% 1564
2020
Q4 		$23K Sell
135
-930
-87% -$108K ﹤0.01% 1741
2020
Q3 		$111K Buy
1,065
+1,019
+2,215% +$252K ﹤0.01% 1503
2020
Q2 		$9K Buy
+46
New +$7.03K ﹤0.01% 1474
2020
Q1 		– Sell
-61
Closed -$8K – 1438
2019
Q4 		$8K Buy
+61
New +$11.4K ﹤0.01% 1096

Other funds holding TRAW

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Huntington National Bank
Huntington National Bank Columbus, Ohio $20.5B AUM 28.07% 1-Year Est. Return

HRT Financial's TRAW Position: Q3 2026 in Review

HRT Financial reduced its Traws Pharma (TRAW) stake by 45% in Q3 2026, selling an estimated $23.6K and leaving 50,102 shares worth $29K. The position accounts for ﹤0.01% of the portfolio, ranked #4439.

HRT Financial first reported a position in TRAW in Q4 2019 and has held it in 8 quarters since. The position peaked at $663K in Q1 2021. 18 funds tracked by Wall St. Rank hold TRAW as of Q3 2026.

  • HRT Financial held 50,102 shares of Traws Pharma worth $29K as of Q3 2026.
  • HRT Financial sold 41,118 Traws Pharma shares in Q3 2026, an estimated $23.6K.
  • Traws Pharma made up ﹤0.01% of HRT Financial's portfolio in Q3 2026, its #4439 holding.
  • HRT Financial first reported a position in Traws Pharma in Q4 2019 and has held it in 8 quarters since.
  • HRT Financial's Traws Pharma position peaked at $663K in Q1 2021.
  • 18 funds tracked by Wall St. Rank held Traws Pharma as of Q3 2026.

Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.